default author photo

Torunn I. Yock

Harvard University - Department of Radiation Oncology

Boston, MA

United States

SCHOLARLY PAPERS

1

DOWNLOADS

100

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Excellent Outcome for Pediatric Patients with High Risk Hodgkin Lymphoma with Brentuximab Vedotin and Risk Adapted Residual Node Radiation

Number of pages: 18 Posted: 29 Oct 2020
St Jude Children’s Research Hospital - Department of Oncology, Stanford University - Division of Pediatric Hematology-Oncology, Nemours/Alfred I. duPont Hospital for Children - Department of Pediatrics, St. Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Radiation Oncology, St Jude Children’s Research Hospital - Division of Nursing Research, St. Jude Children’s Research Hospital - Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital - Department of Oncology, Harvard University - Department of Radiation Oncology, Harvard University - Department of Pediatrics, Department of Pediatric Hematology-Oncology, Peoria, University of Colorado, Aurora - Center for Cancer and Blood Disorders, MaineHealth - Maine Children's Cancer Program, St. Jude Children’s Research Hospital - Department of Oncology, St Jude Children’s Research Hospital - Department of Diagnostic Imaging, St Jude Children’s Research Hospital - Department of Biostatistics, St Jude Children’s Research Hospital - Department of Biostatistics, Stanford University - Department of Radiation Oncology, Stanford University - Department of Radiation Oncology, St Jude Children’s Research Hospital - Department of Oncology and St Jude Children’s Research Hospital - Department of Radiation Oncology
Downloads 100 (689,572)

Abstract:

Loading...

Hodgkin lymphoma, Brentuximab vedotin, residual node radiation, response adapted therapy, pediatric, high-risk, frontline trial